Cerenome (PSTV) Gross Margin (2011 - 2018)
Plus Therapeutics (PSTV) posted quarterly Gross Margin of 26.81% for Q3 2018, up 3109.0% year-over-year from 0.84% in Q3 2017, and up 489.74% quarter-over-quarter from 4.55% in Q2 2018.
Cerenome (PSTV) Gross Margin (2011 - 2018) Analysis & Trends
Plus Therapeutics (PSTV) has reported Gross Margin for 8 consecutive years, with 26.81% the latest figure, recorded in Q3 2018.
- In Q3 2018, Gross Margin rose 3109.0% year-over-year to 26.81%; the TTM figure through Sep 2018 stood at 15.15% (down 312.0% YoY), while the FY2018 annual figure was 68.73%, up 6330.0% from the prior year.
- Gross Margin advanced to 26.81% in Q3 2018 per PSTV's latest filing, from 4.55% in the prior quarter.
- Across five years, Gross Margin topped out at 59.17% in Q1 2014 and bottomed at 21.15% in Q1 2017.
- Historically, Gross Margin has averaged 26.66% across 5 years, with a median of 27.04% in 2017.
- Annual changes were most pronounced in 2017 — Gross Margin slumped 7861 bps — and 2018, when it jumped 4194 bps.
- Plus Therapeutics' Gross Margin stood at 42.65% in 2014, then increased by 15 bps to 49.16% in 2015, then slipped by 28 bps to 35.54% in 2016, then plunged by 88 bps to 4.38% in 2017, then surged by 512 bps to 26.81% in 2018.
- Business Quant data shows PSTV's Gross Margin at 26.81% in Q3 2018, 4.55% in Q2 2018, and 20.79% in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 26.81% |
| Jun 30, 2018 | 4.55% |
| Mar 31, 2018 | 20.79% |
| Dec 31, 2017 | 4.38% |
| Sep 30, 2017 | -4.28% |
| Jun 30, 2017 | 27.04% |
| Mar 31, 2017 | -21.15% |
| Dec 31, 2016 | 35.54% |
| Sep 30, 2016 | 15.46% |
| Jun 30, 2016 | 48.05% |
| Mar 31, 2016 | 57.46% |
| Dec 31, 2015 | 49.16% |
| Sep 30, 2015 | 34.46% |
| Jun 30, 2015 | 19.70% |
| Mar 31, 2015 | 33.81% |
| Dec 31, 2014 | 42.65% |
| Sep 30, 2014 | 34.94% |
| Jun 30, 2014 | 18.07% |
| Mar 31, 2014 | 59.17% |
| Dec 31, 2013 | 58.39% |